It's a synthetic version of a naturally occurring peptide found in the human gastrointestinal system
However, in 4 randomized, placebo-controlled trials, migraine aura was only reported in 1 (2%) of 61 participants who received placebo infusion (isotonic saline) (Fig
This has led researchers to explore alternative delivery routes that maximize cellular uptake, stability, and systemic reach, while minimizing degradation
During this quarter-century, multiple in vitro, in vivo, and in silico studies, as well as clinical trials on this tetrapeptide, have been conducted
FOXO4-DRI Based on 1 publication(s) in Google Scholar FOXO4-DRI is a cell-permeable peptide antagonist that blocks the interaction of FOXO4 and p53